SCHEMBL23309607

SCHEMBL23309607

O=C(Oc1ccccc1)c1cc(F)nc(F)c1F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ HPGD P15428 1/20 0.47
▸ ALOX15 P16050 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ ALDH1A1 P00352 5/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ ADORA3 P0DMS8 1/20 0.44
▸ CHRM1 P11229 1/20 0.44
▸ TBXA2R P21731 1/20 0.44
▸ SLC6A2 P23975 1/20 0.44
▸ PDE4A P27815 1/20 0.44
▸ ADRA1A P35348 1/20 0.44
▸ KDR P35968 1/20 0.44
▸ SLC6A3 Q01959 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309649 0.85 HTT (0.46) MAPTNPSR1TP53SMN1; SMN2KMT2A
SCHEMBL23309616 0.85 ALDH1A1 (0.49) MAPTALDH1A1NPSR1LMNATP53
SCHEMBL23309722 0.81 POLB (0.45) MAPTKDM4EALDH1A1LMNATP53
SCHEMBL23309666 0.80 ALDH1A1 (0.52) MAPTKDM4EHPGDALDH1A1LMNA
SCHEMBL23309596 0.80 MAPT (0.51) MAPTKDM4EHPGDALDH1A1NPSR1
SCHEMBL23309655 0.78 ALDH1A1 (0.53) MAPTKDM4ETDP1ALDH1A1LMNA
SCHEMBL23309550 0.77 NSD2 (0.59) MAPTKDM4ETDP1HPGDALOX15
SCHEMBL23309606 0.76 SMN1; SMN2 (0.38) KDM4ETDP1HPGDHSD17B10ALDH1A1
SCHEMBL23309619 0.75 NPC1 (0.40) MAPTKDM4ETDP1HPGDHSD17B10
SCHEMBL71106 0.74 MAPT (0.69) MAPTKDM4ETDP1HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL MAPT 1126/4885KDM4E 3438/4885TDP1 2586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback